Steve Schonfeld’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-15,000
Closed -$566K – 2414
2025
Q1
$566K Buy
+15,000
New +$1.2M ﹤0.01% 1531

Other funds holding PCVX

Steve Schonfeld's PCVX Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Vaxcyte (PCVX) in Q3 2026: 42,243 shares worth $2.4M. The stake represents 0.01% of the portfolio and ranks #1052 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in PCVX as recently as Q3 2025.

Steve Schonfeld first reported a position in PCVX in Q3 2022 and has held it in 14 quarters since. The position peaked at $13.6M in Q3 2023. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Steve Schonfeld held 42,243 shares of Vaxcyte worth $2.4M as of Q3 2026.
  • Vaxcyte was a new Steve Schonfeld position in Q3 2026.
  • Vaxcyte made up 0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1052 holding.
  • Steve Schonfeld first reported a position in Vaxcyte in Q3 2022 and has held it in 14 quarters since.
  • Steve Schonfeld's Vaxcyte position peaked at $13.6M in Q3 2023.
  • 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.